Two investors sell $860 million in Iqvia shares
Two institutional investors sold more than $860 million worth of stock in Iqvia Holdings Inc. stock on Nov. 30, according to two separate filings earlier this week.
Read MoreIQVIA
Greenville-based Fervent to launch clinical trial for menopause symptom drug
Posted by Barry Teater | Dec 4, 2017
Fervent Pharmaceuticals has successfully submitted an Investigational New Drug application to the FDA for a drug intended to treat menopause symptoms.
Read More
